Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region

[1]  T. Rau,et al.  Phenotype of POLE-mutated endometrial cancer , 2019, PloS one.

[2]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  H. Masuyama,et al.  Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability , 2018, PloS one.

[5]  N. de Wind,et al.  Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues , 2018, Clinical Cancer Research.

[6]  J. Gardovskis,et al.  Detection of Allelic Variants of The POLE and POLD1 Genes in Colorectal Cancer Patients , 2017, Balkan Journal of Medical Genetics : BJMG.

[7]  K. Cole,et al.  Comprehensive Analysis of Hypermutation in Human Cancer , 2017, Cell.

[8]  Tariq Ahmad Masoodi,et al.  Expanding the spectrum of germline variants in cancer , 2017, Human Genetics.

[9]  Tariq Ahmad Masoodi,et al.  Expanding the spectrum of germline variants in cancer , 2017, Human Genetics.

[10]  J. Cubiella,et al.  POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer , 2017, Oncotarget.

[11]  P. Goodfellow,et al.  Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A Subanalysis , 2016, International Journal of Gynecologic Cancer.

[12]  W. Hong,et al.  Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas. , 2016, Gynecologic oncology.

[13]  A. Talhouk,et al.  Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis , 2016, Clinical Cancer Research.

[14]  P. Ng,et al.  SIFT missense predictions for genomes , 2015, Nature Protocols.

[15]  A. Valencia,et al.  POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance , 2015, Genetics in Medicine.

[16]  J. Ngeow,et al.  Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? , 2015, BioMed research international.

[17]  K. Al-Kuraya,et al.  Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer , 2015, Cancer.

[18]  P. Klenerman,et al.  POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer , 2015, Clinical Cancer Research.

[19]  I. Tomlinson.  An update on the molecular pathology of the intestinal polyposis syndromes , 2015 .

[20]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[21]  D. Lambrechts,et al.  Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer , 2014, Journal of the National Cancer Institute.

[22]  H. Morreau,et al.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer , 2014, European Journal of Human Genetics.

[23]  Chris Sander,et al.  Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication , 2014, Genome research.

[24]  C. Lázaro,et al.  New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. , 2014, Human molecular genetics.

[25]  A. Eldali,et al.  Prevalence and severity of pain in cancer patients in an outpatient palliative care setting in Saudi Arabia , 2014, Qatar medical journal.

[26]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[27]  Daniel P. Kane,et al.  A common cancer-associated DNA polymerase ε mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading. , 2014, Cancer research.

[28]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[29]  Peter Donnelly,et al.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.

[30]  Ian Tomlinson,et al.  Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers , 2013, The Journal of pathology.

[31]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[32]  I. Tomlinson,et al.  DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer , 2013, Human molecular genetics.

[33]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[34]  R. Khalil.  Attitudes, beliefs and perceptions regarding truth disclosure of cancer-related information in the Middle East: A review , 2012, Palliative and Supportive Care.

[35]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[36]  Andrea J. O'Hara,et al.  The genomics and genetics of endometrial cancer. , 2012, Advances in genomics and genetics.

[37]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[38]  Andres A. Larrea,et al.  Genome-wide model for the normal eukaryotic DNA replication fork , 2010, Proceedings of the National Academy of Sciences.

[39]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[40]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[41]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[42]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[43]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[44]  R. Broaddus,et al.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[45]  L. Loeb,et al.  DNA polymerases and human disease , 2008, Nature Reviews Genetics.

[46]  T. Kunkel,et al.  Division of labor at the eukaryotic replication fork. , 2008, Molecular cell.

[47]  Z. Jehan,et al.  Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. , 2008, The Journal of clinical endocrinology and metabolism.

[48]  Z. Jehan,et al.  Genome‐wide expression analysis of Middle Eastern papillary thyroid cancer reveals c‐MET as a novel target for cancer therapy , 2007, The Journal of pathology.

[49]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[50]  C Eng,et al.  Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome , 2004, Journal of Medical Genetics.

[51]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[52]  T. Kunkel,et al.  Molecular Cell Letters Who Is Leading the Replication Fork , Pol ε or Pol d ? , 2022 .